Company Profile
VOLPARA HEALTH TECHNOLOGIES LIMITED
It discourages new broking firm formations and has negatively impacted the economic viability of small firms that don’t have access to the elite off-market trading network.Jarden, which was the
Xero’s domination has reduced because several other NZ companies, particularly Zoono, Volpara Health Technologies, Aroa Biosurgery and Neuren, have attracted increasing Australian investor inter
We have contemplated dual listing but we are not – that’s not an active discussion at the moment.”Why is Ryman unenthusiastic about an NZX/ASX dual listing when 14 of the largest 20
Parmer said the companies will drop down from getting 20 percent of their R&D funded to 12.5 percent. Business NZ manufacturing executive director Catherine Beard said, however, the move is positiv
Government investment is seen as the starting point to creating a viable coastal shipping sector.
They call it the Great Resignation – a global phenomenon which has seen people leave their jobs in their droves since the pandemic. But in competitive sectors like advertising and communications, firms are fighting back.
Tourists can expect to see a jump in their hotel bills on the back of reduced availability, and as the industry scrambles to reinvent itself after a two-year hiatus.